Honeywell International (HON.US) announced plans to spin off its advanced materials division into a separate publicly traded company by early 2026. The division, which produces products like Solstice brand refrigerants and industrial solvents, is expected to generate approximately $3.8 billion in revenue in 2024, accounting for about 10% of Honeywell's total sales. The move aligns with CEO Vimal Kapur's strategy to streamline the company's focus on its three main segments: aviation, automation, and the energy transition. The standalone advanced materials business could be valued at over $10 billion.
The spin-off aims to provide greater financial flexibility for future acquisitions, complementing recent purchases totaling over $8 billion including Carrier Global Corp.'s security business for almost $5 billion, CAES Systems Holdings for $1.9 billion, and Air Products and Chemicals Inc.'s liquefied natural-gas technology unit for $1.8 billion. Under CEO Vimal Kapur's leadership since June 2023, Honeywell is refining its portfolio to capitalize on industry megatrends, although the stock's performance has lagged behind the S&P 500's during the same period.
Following the announcement, Honeywell's shares rose nearly 3% in premarket trading to around $207. Currently, the stock has settled at about $206, up approximately 1.6%.
STMicroelectronics shares down 14% amid mixed future outlook📉
Stock of the Week - Merck & Co Inc (23.10.2025)
Beyond Meat after the sell-off📉Is short squeeze still possible?
Banco Macro gains 5% amid US Treasury help to Argentine peso 🗽
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
